COMPLETE Trial: Complete revascularization versus optimal medical therapy to treat residual multi-vessel disease in patients with ST-segment elevation myocardial infarction.
COMPLETE Trial: Complete revascularization versus optimal medical therapy to treat residual multi-vessel disease in patients with ST-segment elevation myocardial infarction.
完整试验：完全血运重建与最佳药物治疗治疗 ST 段抬高型心肌梗死患者残留的多血管疾病。
批准号：
307010
负责人：
Mehta Shamir
金额：
$72.33万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2019-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background: In patients experiencing a heart attack, percutaneous coronary intervention (PCI) promptly relieves the blockage in the "culprit" coronary artery that caused the heart attack. However, in one-third of patients, doctors discover additional "non
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COMPLETE-2: A prospective, randomized, multi-centre trial of physiology-guided versus angiography-guided complete revascularization to treat multivessel disease after early percutaneous coronary intervention for ST-segment elevation myocardial infarction.
-
批准号：420629
-
项目类别：Operating Grants
-
资助金额：$161.34万
-
财政年份：2020
-
负责人：Mehta Shamir
-
依托单位：
海外基金
